A new study will combine an Alzheimer’s medication that slows disease progression in some patients with two other drugs to see if their effects can be amplified.
Menu
Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. The Food and Drug Administration cleared the
Suki, a startup that provides AI tools to help healthcare providers with documentation, billing and other administrative work, raised $70 million in a Series D